Conectus
DYNACURE

Picto Conectus
2016
Health (therapeutic & diagnosis)

DYNACURE

DYNACURE

Description:

  • Biotechnology company developing new treatments for patients with severe orphan disorders.
  • In its first drug discovery program, Dynacure focuses on centronuclear myopathies (CNM), a rare and debilitating disease that affects children and young adults. 

At the origin of the project

  • Jocelyn LAPORTE, Belinda COWLING and Hichem TASFAOUT
  • IGBMC (Institute of Genetics and Molecular and Cellular Biology)
  • CNRS - INSERM - University of Strasbourg

Do you really want to remove this technology from your list ?
close